Randomised Controlled TrialiVNSn = 294

The EMPOWER study: randomized, prospective, double-blind, multicenter trial of vagal blockade to induce weight loss in morbid obesity

Sarr MG, Billington CJ, Brancatisano R, Brancatisano A, Toouli J, Kow L, Nguyen NT, Blackstone R, Maher JW, Shikora S, et al.

Obesity Surgery · 2012

Key finding

In 294 implanted morbidly obese patients, vagal blockade produced 17% excess weight loss at 12 months but did not significantly exceed the control group, which experienced an unexpectedly large response from low-level device current.

Condition
Obesity
Stimulation
iVNS
Evidence tier
Randomised Controlled Trial
Participants
294
View on DOI

Cite this study

Sarr, M. G., Billington, C. J., Brancatisano, R., Brancatisano, A., Toouli, J., Kow, L., Nguyen, N. T., Blackstone, R., Maher, J. W., Shikora, S., Reeds, D. N., Eagon, J. C., Wolfe, B. M., O’Rourke, R. W., Fujioka, K., Takata, M., Swain, J. M., Morton, J. M., Ikramuddin, S., … Rosenthal, R. (2012). The EMPOWER study: randomized, prospective, double-blind, multicenter trial of vagal blockade to induce weight loss in morbid obesity. Obesity Surgery, 22(11), 1771-1782. https://doi.org/10.1007/s11695-012-0751-8

Related studies in Obesity

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.